BU-NOT-SET

CONTACT US
Developing a robust dissolution method for low-dose formulations
  • Analytical chemistry
  • Drug product
low-dose formulation
White paper
Sustainability report 2022
  • Sustainability
Sustainability report 2022
Report
Navigating the changing oral solid dose landscape
  • Drug product
  • Industry trends
Oral solid dose
Insight
The opportunities and obstacles of filling and packaging pre-filled syringes
  • Drug product
  • Manufacturing
pre-filled syringes
Insight
Tips for facilitating a successful tech transfer between sponsor and CDMO
  • Drug product
  • Industry trends
Tech transfer
Insight
Alternative drug delivery formulation & device expertise
  • Drug product
  • Industry trends
Industry trends
Insight
The 3 key trends shaping the CDMO industry in 2023 and beyond
  • Industry trends
CDMO trends
Insight
Three challenges pharma companies can overcome when choosing the right OSD partner
  • Drug product
  • Industry trends
pharma challenges
Insight
Sustainable pharmaceutical supply chains with the Science Based Targets initiative
  • Sustainability
SBTi
Insight
Insight
How CDMO partnerships can accelerate vaccine development
Insight
  • Analytical chemistry
  • Drug product
Optimising extractables and leachables testing
Fact sheet
  • Drug product
  • Manufacturing
Ready-to-use (RTU) pre-filled syringes and cartridges system
Insight
  • Drug product
  • Manufacturing
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
Insight
  • Drug product
  • Industry trends
Which biologics trends in the OSD space are set to impact drug development in 2023?
Insight
  • Drug product
  • Industry trends
What are the key learnings from 2022 in pharma?
Insight
  • Drug product
  • Manufacturing
Overcoming the pitfalls of pre-filled syringe filling
Insight
  • Drug product
  • Industry trends
2023: fill and finish demand expected to continue as the industry faces new challenges
Insight
  • Drug product
  • Industry trends
What does 2023 hold for oral solid dosage forms?